FFCP PHASE2:Mm9::chr5:115223381..115223481,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p1@Git2 |
|---|---|
| Species: | Mouse (Mus musculus) |
| DPI dataset: | NA |
| TSS-like-by-RIKEN-classifier(Yes/No): | NA |
| DHS support(Yes/No): | NA |
| Description: | CAGE_peak_1_at_Git2_5end |
| Coexpression cluster: | MCL_coexpression_mm9:36 |
| Association with transcript: | 0bp_to_ENSMUST00000086564, ENSMUST00000112183, ENSMUST00000133096_5end |
| EntrezGene: | Git2 |
| Link to Zenbu: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@Git2 |
|---|
0
20
40
60
80
100
120
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| lymphoid lineage restricted progenitor cell | 1.31e-07 | 12 |
| T cell | 4.22e-07 | 11 |
| pro-T cell | 4.22e-07 | 11 |
| hematopoietic cell | 8.28e-07 | 32 |
| hematopoietic oligopotent progenitor cell | 8.28e-07 | 32 |
| hematopoietic stem cell | 8.28e-07 | 32 |
| hematopoietic multipotent progenitor cell | 8.28e-07 | 32 |
Showing 1 to 7 of 7 entries
| Ontology term | p-value | n |
|---|---|---|
| hematopoietic system | 7.38e-13 | 45 |
| blood island | 7.38e-13 | 45 |
| lateral plate mesoderm | 1.15e-12 | 87 |
| hemolymphoid system | 3.28e-12 | 48 |
| immune system | 3.28e-12 | 48 |
| mixed endoderm/mesoderm-derived structure | 1.76e-10 | 35 |
| hemopoietic organ | 1.78e-09 | 29 |
| immune organ | 1.78e-09 | 29 |
| respiratory system | 2.34e-09 | 42 |
| respiratory tract | 5.00e-09 | 41 |
Showing 1 to 10 of 29 entries
